| scholarly article | Q13442814 |
| P2093 | author name string | Keiichi Ozono | |
| Toshimi Michigami | |||
| Shigeki Shimba | |||
| Masanobu Kawai | |||
| Saori Kinoshita | |||
| P2860 | cites work | Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 | Q24290481 |
| Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis | Q24300249 | ||
| Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 | ||
| Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism | Q26852624 | ||
| Regulation and function of the FGF23/klotho endocrine pathways | Q26860470 | ||
| Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation | Q27318655 | ||
| Protein tyrosine kinase structure and function | Q28145008 | ||
| Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
| Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism | Q28508765 | ||
| PKCγ participates in food entrainment by regulating BMAL1 | Q28509322 | ||
| PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop | Q28575895 | ||
| Regulation of fibroblast growth factor-23 signaling by klotho | Q28587100 | ||
| Leptin regulation of bone resorption by the sympathetic nervous system and CART | Q28589974 | ||
| Transplanted suprachiasmatic nucleus determines circadian period | Q29616365 | ||
| Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus | Q29619114 | ||
| Circadian integration of metabolism and energetics | Q29619638 | ||
| The meter of metabolism | Q29619740 | ||
| Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 | ||
| Evolution of motif variants and positional bias of the cyclic-AMP response element | Q33272841 | ||
| System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock | Q33273610 | ||
| Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets | Q33645895 | ||
| Cellular bioenergetics as a target for obesity therapy | Q33894407 | ||
| Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers | Q33974129 | ||
| Leptin regulates bone formation via the sympathetic nervous system | Q34157988 | ||
| Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status | Q34262497 | ||
| Phosphate sensing | Q34690795 | ||
| Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. | Q35728669 | ||
| The role of Klotho in energy metabolism | Q36992839 | ||
| Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia | Q37072659 | ||
| Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression | Q37482097 | ||
| Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells | Q38051976 | ||
| Bone formation regulates circulating concentrations of fibroblast growth factor 23. | Q39788869 | ||
| 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport | Q40397501 | ||
| SOST is a target gene for PTH in bone | Q40411595 | ||
| FGF23 is processed by proprotein convertases but not by PHEX. | Q40532892 | ||
| Relation of obesity and diet to sympathetic nervous system activity | Q41183282 | ||
| Effect of starvation and food intake on sympathetic activity | Q41373398 | ||
| Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. | Q42493065 | ||
| Fibroblast growth factor 23 production in bone is directly regulated by 1α,25-dihydroxyvitamin D, but not PTH | Q42925810 | ||
| Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice | Q44142771 | ||
| Biological variability of plasma intact and C-terminal FGF23 measurements | Q45399588 | ||
| Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system | Q46551331 | ||
| Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism | Q46585085 | ||
| ASPECTS OF CIRCADIAN PERIODIC CHANGES IN PHOSPHORUS METABOLISM IN MICE. | Q51276485 | ||
| The molecular clock mediates leptin-regulated bone formation. | Q52040136 | ||
| Increase in muscle nerve sympathetic activity in humans after food intake | Q72329326 | ||
| Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men | Q79298180 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | circadian rhythm | Q208353 |
| P304 | page(s) | 1457-1466 | |
| P577 | publication date | 2013-12-03 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner | |
| P478 | volume | 289 |
| Q47704837 | 24-hour profile of serum sclerostin and its association with bone biomarkers in men. |
| Q62597853 | A Controlled Increase in Dietary Phosphate Elevates BP in Healthy Human Subjects |
| Q30313507 | Advanced glycation end products stimulate gene expression of fibroblast growth factor 23. |
| Q64054921 | Bone marrow and plasma FGF-23 in heart failure patients: novel insights into the heart-bone axis |
| Q58770788 | Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II |
| Q39024187 | Control of phosphate balance by the kidney and intestine. |
| Q53810866 | Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment. |
| Q37152270 | Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23. |
| Q30315564 | Fibroblast growth factor (Fgf) 23 gene transcription depends on actin cytoskeleton reorganization. |
| Q35797940 | Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study |
| Q40279706 | Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis |
| Q35008805 | Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial |
| Q28086929 | Functional diversity of fibroblast growth factors in bone formation |
| Q58743905 | Hypophosphatemia Regulates Molecular Mechanisms of Circadian Rhythm |
| Q88540268 | Impact of the Autonomic Nervous System on the Skeleton |
| Q58548730 | Insights into the Role of Circadian Rhythms in Bone Metabolism: A Promising Intervention Target? |
| Q91731419 | Melatonin is a potential drug for the prevention of bone loss during space flight |
| Q93076198 | Nerves in Bone: Evolving Concepts in Pain and Anabolism |
| Q28083419 | Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep |
| Q90264158 | Phosphate wasting disorders in adults |
| Q47578293 | The importance of the circadian system & sleep for bone health. |
| Q30234695 | The systemic nature of CKD. |
Search more.